Hemoglobin Orsense and Laboratory Measurement

This study has been completed.
Sponsor:
Information provided by:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT01321593
First received: March 19, 2011
Last updated: June 4, 2011
Last verified: June 2011
  Purpose

The purpose of this study is to compare the hemoglobin results obtained with the Orsense device and the Clinical Laboratory.


Condition
Emergency

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of the Hemoglobin Results Obtained With the Orsense Device and the Clinical Laboratory

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Hemoglobin measurement using the Orsense device [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: February 2011
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
hemogobin determination
emergency unit patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

emergency unit patients requiring an hemoglobin determination

Criteria

Inclusion Criteria:

  • emergency unit patients requiring an hemoglobin determination

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01321593

Locations
France
Hôpital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Investigators
Study Chair: Marc Fischler, MD Hôpital Foch
  More Information

No publications provided by Hopital Foch

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Pr Fischler, Hopital Foch
ClinicalTrials.gov Identifier: NCT01321593     History of Changes
Other Study ID Numbers: 2010/28
Study First Received: March 19, 2011
Last Updated: June 4, 2011
Health Authority: France: Direction Générale de la Santé

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on April 23, 2014